Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

61.90
Delayed Data
As of Dec 09
 -0.20 / -0.32%
Today’s Change
44.16
Today|||52-Week Range
71.87
-11.82%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Biotech & Pharma ETFs to Suffer in 2017 Too?
Dec 08 / Zacks.com - Paid Partner Content
Dow Scores Another Record for Third Consecutive Day; S&P 500 Also Hits New High
Dec 07 / TheStreet.com - Paid Partner Content
Bad Day for Biotechs Means It's Time to Buy
Dec 07 / TheStreet.com - Paid Partner Content
Trump Vows to Slash Drug Prices, Sends Biotech Stocks Lower
Dec 07 / Zacks.com - Paid Partner Content
Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Mo...
Dec 07 / TheStreet.com - Paid Partner Content
Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally
Dec 07 / TheStreet.com - Paid Partner Content

Performance

1 month-3.58% 3 years+14.25%
3 months+1.23% 5 years+24.27%
1 year-7.54% Since inception+13.37%
Data through 12/10/2016

Quote Details

Previous close$62.10
Open day’s range61.83 – 63.77
Net asset value (NAV)61.95 (12/09/2016)
Daily volume6,275,590
Average volume (3 months)6,733,917
Data as of 7:59pm ET, 12/09/2016

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+24.27%+20.19%
Expense Gross exp ratio0.35%1.31%
Risk 5 year sharpe ratio0.851.11
Net assets$3.1B$2.9B
Average market cap$4.8B$31.6B
Average P/E--18.6
Dividend / Share--0.26%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
IONS Ionis Pharmaceuticals Inc3.65%
TSRO TESARO Inc3.59%
INCY Incyte Corp3.13%
EXEL Exelixis Inc3.10%
SRPT Sarepta Therapeutics Inc3.05%
CELG Celgene2.75%
UTHR United Therapeutics Corp2.54%
RARE Ultragenyx Pharmaceutical Inc2.53%
ARIA ARIAD Pharmaceuticals Inc2.44%
BLUE bluebird bio Inc2.41%

Search for Jobs